1-3 of 3
Vincent Launay
Close
Sort by
Journal Articles

Nivolumab First-Line Therapy for Elderly, Frail Hodgkin Lymphoma Patients: Niviniho, a Lysa Phase II Study

Julien Lazarovici, Sandy Amorim, Krimo Bouabdallah, Stéphanie Guidez, Lysiane Molina, Franck Morschhauser, Anne-Claire Gac, Thomas Gastinne, Kamel Laribi, Vincent Launay, Bohrane Slama, Nawel Belmecheri, René-Olivier Casasnovas, Anne Corby, Eric Durot, Pierre Feugier, Emmanuelle Nicolas-Virelizier, David Sibon, Alina Berriolo-Riedinger, Veronique Edeline, Thierry Vander Borght, Diane Damotte, Alexandra Traverse-Glehen, Marc Andre, Vincent Ribrag
Journal: Blood
Blood (2021) 138 (Supplement 1): 232.
https://doi.org/10.1182/blood-2021-147863
Published: 2021
Journal Articles

TP53 Mutation Profile and New Mutations in Chronic Lymphocytic Leukemia in Normandy

Nordine Lahyane, Julien Alani, Xavier Troussard, MD, PhD, Stephane Cheze, MD, Jean-Pierre Vilque, MD, Seyeffedine Kadi, MD, Vincent Launay, MD, Edouard Cornet, MD, Dina Istasi, MBBCH, MD, CES
Journal: Blood
Blood (2011) 118 (21): 4593.
https://doi.org/10.1182/blood.V118.21.4593.4593
Published: 2011
Journal Articles

Frequency of Complete Molecular Response In Chronic Myeloid Leukemia Patients In Real Life Practice.

Matthieu Decamp, Dina Istasi, MBBCH, MD, CES, Atchroue Johnsonansah, Oumedaly Reman, Xavier Levaltier, Christophe Fruchart, MD, Vincent Launay, Seyeffedine Kadi, Xavier Troussard
Journal: Blood
Blood (2010) 116 (21): 1227.
https://doi.org/10.1182/blood.V116.21.1227.1227
Published: 2010